DATA STORY · SEARCH VS EVIDENCE
5 peptides searched over 10,000 times a month in the US have 1 to 5 registered trials
BPC-157 (44,000 searches a month, 3 trials); Ipamorelin (29,000 searches a month, 3 trials); MOTS-c (23,000 searches a month, 5 trials); GHK-Cu (17,000 searches a month, 3 trials); CJC-1295 (11,000 searches a month, 1 trial). Of the 27 tracked peptides searched over 10,000 times a month, these 5 have 5 or fewer registered trials.
CHART
US monthly searches per registered trial, top 12
| BPC-157 | 44,000 searches, 3 trials |
|---|---|
| CJC-1295 | 11,000 searches, 1 trial |
| Retatrutide | 335,000 searches, 33 trials |
| Ipamorelin | 29,000 searches, 3 trials |
| DSIP | 8,400 searches, 1 trial |
| TB-500 | 6,200 searches, 1 trial |
| GHK-Cu | 17,000 searches, 3 trials |
| MOTS-c | 23,000 searches, 5 trials |
| Sermorelin | 119,000 searches, 27 trials |
| Tesamorelin | 71,000 searches, 24 trials |
| Tirzepatide | 673,000 searches, 277 trials |
| Bacitracin | 64,000 searches, 53 trials |
Source: ClinicalTrials.gov; Ahrefs Keywords Explorer (US), read 2026-09-04.
THE FIGURES
- Searches: US monthly average over the last 12 months, Ahrefs, read 2026-10-01.
- Trials: registered on ClinicalTrials.gov, read 2026-09-04.
- Most searches per trial: BPC-157, 14,667 searches a month per registered trial.
METHOD
Searches per trial is the US monthly search volume for the peptide's name divided by its number of registered trials. TB-500 counts only trials of TB-500, not of full-length thymosin beta-4. Search volume is an Ahrefs estimate.
Free to quote and chart with a link to this page. Not medical, legal or regulatory advice.
WEEKLY
Register Watch, weekly
New trials, approvals and enforcement actions. One email a week.